Volume 14, Number 6—June 2008
Letter
Lethal Mycobacterium massiliense Sepsis, Italy
Enrico Tortoli*
, Rita Gabini†, Irene Galanti†, and Alessandro Mariottini*
, Rita Gabini†, Irene Galanti†, and Alessandro Mariottini*
Table
Antimicrobial drug resistance pattern of the strain of Mycobacterium massiliense isolated from the patient, Italy*
| Drug | MIC (μg/mL) | Pattern |
|---|---|---|
| Amikacin | 4 | S |
| Amoxicillin/clavulanic acid | 64/32 | R |
| Cefoxitin | 64 | I |
| Ceftriaxone | >64 | R |
| Ciprofloxacin | 16 | R |
| Clarithromycin | <0.12 | S |
| Gatifloxacin | >8 | R |
| Imipenem | 32 | R |
| Linezolid | 8 | S |
| Tobramycin | 16 | R |
| Trimethoprim/sulfamethoxazole | 8/152 | R |
*S, sensitive; R, resistant; I, intermediate resistance.
Page created: July 09, 2010
Page updated: July 09, 2010
Page reviewed: July 09, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.